| 5-HT | Serotonin |
| ACG | Actigraphy |
| ACh | Acetylcholine |
| AHI | Apnea-hypoapnea index |
| AIS | Athens Insomnia Scale |
| ALA | Alpha-linolenic acid |
| AM | Ante meridiem |
| APOE | Apolipoprotein E |
| ASBQ | Athlete Sleep Behavior Questionnaire |
| ASSQ | Athlete Sleep Screening Questionnaire |
| ATP | Adenosine triphosphate |
| BAX | Bcl-2 associated X protein |
| BCL2 | B-cell lymphoma protein 2 |
| BDNF | Brain-derived neurotrophic factor |
| Bglap2 | Osteocalcin |
| BMAL1 | Brain and muscle ARNT-like protein 1 |
| Bsp | Bone sialoprotein |
| CBD | Compound cannabidiol |
| CBT-I | Cognitive Behavioural Therapy for Insomnia |
| CCAR2 | Apoptosis regulator 2 |
| CO2 | Carbon dioxide |
| DFUs | Diabetic foot ulcers |
| DHA | Docosahexaenoic acid |
| Dmp1 | Dentin matrix protein 1 |
| EEG | Electroencephalogram |
| EPA | Eicosapentaenoic acid |
| FODMAP | Fermentable oligosaccharides, monosaccharides, and polyols |
| GABA | Gamma-aminobutyric acid |
| GH | Growth hormone |
| GI | Glycemic Index |
| ID | Insomnia Disorder |
| IGF-1 | Insulin-like growth factor 1 |
| IL-1β | Interleukin-1β |
| IL-6 | Interleukin 6 |
| IOC | International Olympic Committee |
| ISI | Insomnia Severity Index |
| LEA | Low energy availability |
| MCTQ | Munich Chronotype Questionnaire |
| MEQ | Morningness-Eveningness Questionnaire |
| MyoD | Myoblast determination protein |
| NaSSA | Noradrenergic and specific serotonergic antidepressant |
| NCAA | National Collegiate Athletic Association |
| NGF | Nerve growth factor |
| NO | Nitric oxide |
| NREM | Non-rapid eye movement |
| OSA | Obstructive sleep apnea |
| PET | Positron emission tomography |
| PGO | Ponto-geniculo-occipital |
| PM | Post meridiem |
| PSG | Polysomnography |
| PSQI | Pittsburgh Sleep Quality Index |
| PUFA | Polyunsaturated fatty acid |
| REM | Rapid eye movement |
| RHT | Retino-hypothalamic tract |
| RLS | Restless legs syndrome |
| SCN | Hypothalamic suprachiasmatic nucleus |
| SD | Sleep disorders |
| SIRT1 | Sirtuin 1 |
| SHY | Synaptic Homeostasis Hypothesi |
| Spp1 | Osteopontin |
| THC | Tetrahydrocannabinol |
| TNF-α | Tumor necrosis factor-α |
| TUE | Therapeutic Use Exemption |
| WADA | World Anti-Doping Agency |
| WASO | Wakefulness after sleep onset |